Can Vaccine Allocation Plans Legally Respond to Racial Disparities?
Can COVID-19 vaccine allocation legally recognize the outsized burden of cases and deaths that racial/ethnic minority communities have borne?

Knowing more about the ways that viruses spread could help us avoid the pitfalls of declaring victory too early.

Under existing federal statutes and case law, colleges and universities have broad discretion to require vaccination as a condition of a return to campus.

Russian and Chinese troll farms, news providers, and social media influencers are attacking Moderna, Pfizer, and AstraZeneca COVID vaccines.

The difficult manufacturing issues involved in the therapeutic antibody context, and what might be done to address them.

Businesses that require vaccines under EUA are taking a legal risk, but also have good legal arguments for the mandates.

The rapid development of therapeutic antibodies is a triumph of biomedical innovation. But they won’t help unless they make it to patients.

A rubric of laws making mandatory programs complicated to deploy is leading many employers to favor vaccine encouragement policies.

Should smoking be among the pre-existing health risks that qualify people for priority access to the COVID-19 vaccine?
